These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37833850)

  • 1. PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury.
    Qian B; Wang C; Li X; Ma P; Dong L; Shen B; Wu H; Li N; Kang K; Ma Y
    Liver Int; 2023 Dec; 43(12):2808-2823. PubMed ID: 37833850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats.
    Collino M; Benetti E; Miglio G; Castiglia S; Rosa AC; Aragno M; Thiemermann C; Fantozzi R
    Free Radic Biol Med; 2011 Jan; 50(2):345-53. PubMed ID: 21047550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury.
    Sarre C; Contreras-Lopez R; Nernpermpisooth N; Barrere C; Bahraoui S; Terraza C; Tejedor G; Vincent A; Luz-Crawford P; Kongpol K; Kumphune S; Piot C; Nargeot J; Jorgensen C; Djouad F; Barrere-Lemaire S
    Stem Cell Res Ther; 2022 Apr; 13(1):167. PubMed ID: 35461240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective Effects of PPARβ/δ Activation against Ischemia/Reperfusion Injury in Rat Heart Are Associated with ALDH2 Upregulation, Amelioration of Oxidative Stress and Preservation of Mitochondrial Energy Production.
    Papatheodorou I; Galatou E; Panagiotidis GD; Ravingerová T; Lazou A
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological activation of PPARβ/δ preserves mitochondrial respiratory function in ischemia/reperfusion
    Papatheodorou I; Makrecka-Kuka M; Kuka J; Liepinsh E; Dambrova M; Lazou A
    Front Endocrinol (Lausanne); 2022; 13():941822. PubMed ID: 36046786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARγ Mediates Protective Effect against Hepatic Ischemia/Reperfusion Injury via NF-κB Pathway.
    Liu X; Zhang P; Song X; Cui H; Shen W
    J Invest Surg; 2022 Aug; 35(8):1648-1659. PubMed ID: 35732295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
    Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
    J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR
    Lu W; Huang J; Flores J; Li P; Wang W; Liu S; Zhang JH; Tang J
    Exp Neurol; 2024 Feb; 372():114615. PubMed ID: 37995951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
    Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of peroxisome proliferator-activated receptor-β/δ in septic shock.
    Kapoor A; Shintani Y; Collino M; Osuchowski MF; Busch D; Patel NS; Sepodes B; Castiglia S; Fantozzi R; Bishop-Bailey D; Mota-Filipe H; Yaqoob MM; Suzuki K; Bahrami S; Desvergne B; Mitchell JA; Thiemermann C
    Am J Respir Crit Care Med; 2010 Dec; 182(12):1506-15. PubMed ID: 20693380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase-2 enhances inhibition of skin tumorigenesis.
    Bility MT; Zhu B; Kang BH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2010 Jan; 113(1):27-36. PubMed ID: 19748995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
    Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
    Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
    Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
    Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome Proliferator-Activated Receptor β/δ Alleviates Early Brain Injury After Subarachnoid Hemorrhage in Rats.
    Teng Z; Jiang L; Hu Q; He Y; Guo Z; Wu Y; Huang Z; Cao F; Cheng C; Sun X; Guo Z
    Stroke; 2016 Jan; 47(1):196-205. PubMed ID: 26628385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Peroxisome Proliferator Activator Receptor β/δ Improves Endothelial Dysfunction and Protects Kidney in Murine Lupus.
    Romero M; Toral M; Robles-Vera I; Sánchez M; Jiménez R; O'Valle F; Rodriguez-Nogales A; Pérez-Vizcaino F; Gálvez J; Duarte J
    Hypertension; 2017 Apr; 69(4):641-650. PubMed ID: 28242713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.
    Han S; Ritzenthaler JD; Zheng Y; Roman J
    Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1238-49. PubMed ID: 18390835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor beta/delta activation improves angiotensin II-induced cardiac hypertrophy in vitro.
    Sheng L; Ye P; Liu YX; Han CG; Zhang ZY
    Clin Exp Hypertens; 2008 Feb; 30(2):109-19. PubMed ID: 18293166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of peroxisome proliferator-activated receptor-beta/delta attenuates myocardial ischemia/reperfusion injury in the rat.
    Kapoor A; Collino M; Castiglia S; Fantozzi R; Thiemermann C
    Shock; 2010 Aug; 34(2):117-24. PubMed ID: 19997057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.